Controversies and strengths of robot-assisted mastectomy.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
PMID:

Abstract

Nipple-sparing mastectomy (NSM) is used to improve cosmetic outcomes while maintaining oncological safety in patients with early breast cancer; however, NSM requires a higher level of skill and workload than mastectomy and is associated with long, visible scars. Robotic surgical systems reduce surgeon workload and facilitate precise surgery. Considering the increasing support of robot-assisted NSM (RNSM), this paper aims to discuss the current controversies based on the research findings reported thus far. There are four concerns regarding RNSM; increased cost, oncological outcomes, the level of experience and skill, and standardization. It should be noted that RNSM is not a surgery performed on all patients but rather a procedure performed on selected patients who meet specific indications. A large-scale randomized clinical trial comparing robotic and conventional NSM has recently begun in Korea; therefore, it is necessary to wait for these results for more insight into oncological outcomes. Although the level of experience and skill required for robotic mastectomy may not be easily achieved by all surgeons, the learning curve for RNSM appears manageable and can be overcome with appropriate training and practice. Training programs and standardization efforts will help improve the overall quality of RNSM. There are some advantages to RNSM. The robotic system provides improved precision and accuracy, helping remove breast tissue more effectively. RNSM has advantages such as smaller scars, less blood loss, and a lower rate of surgical complications. Patients who undergo RNSM report better quality of life.

Authors

  • Joo Heung Kim
    Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Gyeonggi, Korea.
  • Antonio Toesca
    Division of Breast Surgery, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Giada Pozzi
    Division of Breast Surgery, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Guglielmo Gazzetta
    Division of Breast Surgery, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Emilia Marrazzo
    Breast Unit, Department of Surgery, Ospedale Maggiore di Lodi, Lodi, Italy.
  • Hyung Seok Park
    Department of Surgery, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. hyungseokpark.md@gmail.com.